After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...

The primary aim of the study is to evaluate Spectris' efficacy in slowing the progression of Alzheimer’s against sham for ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

USC researchers have found a promising new brain scan marker that could better detect Alzheimer’s risk — but only for some.

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson's disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a ...

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...